United Therapeutics CORP Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
NASDAQ
Martine A Rothblatt, Chairperson & CEO and a Director of UNITED THERAPEUTICS Corp, sold 9,500 shares of common stock on August 12, 2026.
NASDAQ
Martine A Rothblatt, Chairperson & CEO and a Director of UNITED THERAPEUTICS Corp, sold 9,500 shares of common stock on August 11, 2026.
NASDAQ
Martine A Rothblatt, Chairperson & CEO and a Director of UNITED THERAPEUTICS Corp, sold 9,500 shares of common stock on August 7, 2026.
NASDAQ
Martine A Rothblatt, Chairperson & CEO and a Director of UNITED THERAPEUTICS Corp, sold 9,500 shares of common stock on August 6, 2026.
NASDAQ
Paul A Mahon, EVP & GENERAL COUNSEL of UNITED THERAPEUTICS Corp, sold 8,300 shares of common stock on August 6, 2026.
NASDAQ
Martine A Rothblatt, Chairperson & CEO and a Director of UNITED THERAPEUTICS Corp, sold 9,500 shares of common stock on August 5, 2026.
NASDAQ
Martine A Rothblatt, Chairperson & CEO and a Director of UNITED THERAPEUTICS Corp, sold 9,500 shares of common stock on August 4, 2026.
NASDAQ
Martine A Rothblatt, Chairperson & CEO and a Director of UNITED THERAPEUTICS Corp, sold 9,500 shares of common stock on July 30, 2026.
NASDAQ
Martine A Rothblatt, Chairperson & CEO and a Director of UNITED THERAPEUTICS Corp, sold 9,500 shares of common stock on July 29, 2026.
NASDAQ
Martine A Rothblatt, Chairperson & CEO and a Director of UNITED THERAPEUTICS Corp, sold 9,500 shares of common stock on July 28, 2026.
NASDAQ
Martine A Rothblatt, Chairperson & CEO and a Director of UNITED THERAPEUTICS Corp, sold 9,500 shares of common stock on July 27, 2026.
NASDAQ
Martine A Rothblatt, Chairperson & CEO and a Director of UNITED THERAPEUTICS Corp, sold 9,500 shares of common stock on July 24, 2026.
NASDAQ
Martine A Rothblatt, Chairperson & CEO and a Director of UNITED THERAPEUTICS Corp, sold 9,500 shares of common stock on July 23, 2026.
NASDAQ
Victor J Dzau, a Director of UNITED THERAPEUTICS Corp, reported multiple transactions in common stock on July 22, 2026.
NASDAQ
Linda Maxwell, a Director of UNITED THERAPEUTICS Corp, reported multiple transactions in common stock on July 22, 2026.
NASDAQ
Tommy G Thompson, a Director of UNITED THERAPEUTICS Corp, reported multiple transactions in common stock on July 22, 2026.
NASDAQ
Kevin Tracey, a Director of UNITED THERAPEUTICS Corp, received 760 shares of common stock on July 22, 2026.
NASDAQ
Judy D. Olian, a Director of UNITED THERAPEUTICS Corp, received 760 shares of common stock on July 22, 2026.
NASDAQ
Jan Malcolm, a Director of UNITED THERAPEUTICS Corp, reported multiple transactions in common stock on July 22, 2026.
NASDAQ
Nilda Mesa, a Director of UNITED THERAPEUTICS Corp, reported multiple transactions in common stock on July 22, 2026.
NASDAQ
Louis W Sullivan, a Director of UNITED THERAPEUTICS Corp, received 2,380 shares of common stock on July 22, 2026.
NASDAQ
Christopher Causey, a Director of UNITED THERAPEUTICS Corp, received 2,380 shares of common stock on July 22, 2026.
NASDAQ
Christopher Patusky, a Director of UNITED THERAPEUTICS Corp, received 2,380 shares of common stock on July 22, 2026.
NASDAQ
Richard Giltner, a Director of UNITED THERAPEUTICS Corp, received 760 shares of common stock on July 22, 2026.
NASDAQ
Ray Kurzweil, a Director of UNITED THERAPEUTICS Corp, reported multiple transactions in common stock on July 22, 2026.
NASDAQ
Martine A Rothblatt, Chairperson & CEO and a Director of UNITED THERAPEUTICS Corp, sold 9,500 shares of common stock on July 22, 2026.
NASDAQ
Martine A Rothblatt, Chairperson & CEO and a Director of UNITED THERAPEUTICS Corp, sold 9,500 shares of common stock on July 21, 2026.
NASDAQ
Martine A Rothblatt, Chairperson & CEO and a Director of UNITED THERAPEUTICS Corp, sold 9,500 shares of common stock on July 20, 2026.
NASDAQ
Martine A Rothblatt, Chairperson & CEO and a Director of UNITED THERAPEUTICS Corp, sold 9,500 shares of common stock on July 17, 2026.
NASDAQ
Martine A Rothblatt, Chairperson & CEO and a Director of UNITED THERAPEUTICS Corp, sold 9,500 shares of common stock on July 16, 2026.